Key facts
- Innovu’s last known valuation is $95.0M (Jun 2021).
- It has raised $55.2M across 20 recorded rounds; the latest was Seed Round ($1.3M) in Dec 2025.
- Notable investors include Red Brick Capital Partners, Adams Capital Management, Grouse Ridge Capital, Jim O'Neill, Joel Adams.
- Innovu has filed 23 Form Ds with the SEC since 2015, most recently Feb 2024 ($3.0M sold to 34 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 20 rounds
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Innovu
Funding rounds
20 roundsAbout Innovu
Developer of a health data management and analytics platform designed to uncover insights from disparate silos of benefit and risk data. The company's platform integrates and validates all data sources into a single secure cloud space to help clients gain control of their data and generate a full view of their population, enabling clients to use the total rewards and risk data differently to manage and mitigate business and population risk.
- Sector
- Information Technology
- HQ
- Pittsburgh, PA, United States
- Founded
- 2014
- Employees
- 89
- Website
- innovu.com/
- Ownership
- Privately Held (backing)
Innovu doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Innovu shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Innovu in its N-PORT filings yet. We sweep new filings monthly.